Background: Clear cells are observed histopathologically in both benign and malignant neoplasms but their presence in salivary gland tumors has not been extensively documented. Material and Methods: With IRB approval, the archive of the University of Florida College of Dentistry oral pathology biopsy service was retrospectively searched from 1994-2014 for all benign and malignant salivary tumors. Epidemiological data, tumor location and duration, and type of tumor were recorded. A four reviewer panel examined the original slides. Reviewers scaled each case as 0 (no clear cells present), 1 (few to focal clear cells), 2 (less than 50% clear cells), and 3 (greater than 50% clear cells). Results: A total of 535 cases were included of which 48% of tumors displayed 0 clear cells (257/535), 31.4% (168/535) scored 1, 13.6% (73/535) scored 2, and 7% (37/535) scored 3. Of the 251 (47%) malignant neoplasms, 64% (160/251) demonstrated 0-1 clear cell change, while 36% (91/251) showed a score of 2-3. For the total 284 (53%) benign tumors, 93% (265/535) scored 0-1 and 7% (19/535) scored a 2-3 range. No statistical difference was noted for gender, age, or duration of time present in regards to presence or absence of clear cells. Statistically significant differences in clear cell presence were found between location groups, between benign and malignant diagnosis, and between specific diagnostic groups. Conclusions: This study demonstrates the frequent presence of increased numbers of clear cells in oral salivary malignancies and highlights salivary gland differential diagnoses when presented with clear cell changes.
Introduction
Clear cells may be found as incidental histologic findings in a multitude of benign or malignant tumors of many cell origins including epithelial, melanocytic, mesenchymal, or hematopoietic (1) . They may be a result of many different processes, including artifact, degeneration of cellular organelles, or accumulation of substances within the cells -most commonly glycogen, but sometimes mucopolysaccharides, mucin, lipids, or foreign bodies (1, 2) . Within the head and neck region, clear cells are found most commonly in salivary gland tumors, but also may be seen in tumors of squamous or odontogenic epithelial origin, primary or metastatic carcinoma, benign or malignant melanocytic lesions, or benign or malignant mesenchymal tumors (1, 3) . Knowledge of the frequency and patterns of clear cell presentation in salivary gland tumors may be helpful in determining a diagnosis. This study serves to describe both the epidemiologic, clinical, and histologic features of a large series of salivary tumors and also to detail the occurrence and histologic appearance of clear cells found within this group of tumors.
Material and Methods
Institutional review board approval and permission for waiver of informed consent was granted from the University of Florida Institutional Review Board Ethics Committee (Approval #IRB201400598). We identified 641 cases of salivary tumors in the archive files of the University of Florida College of Dentistry's Oral Pathology Laboratory (Gainesville, FL) dating from January 1994-January 2014. Epidemiologic data was collected to include age, gender, diagnosis, site of occurrence, and time period the lesion was present. In instances where both an incisional and excisional specimen were available, the excisional specimen was chosen for examination in the study. Metastatic tumors and cases with insufficient tissue were excluded from the study. Hematoxylin and eosin stained slides were examined for each tumor by a panel of four Oral and Maxillofacial Pathologists (IB, DC, MI, SF). Clear cell changes were tabulated for each case with the following criteria: tumors with no clear cells present = grade 0 (negative); those with few to focal clear cells (less than 25%) = grade 1 (focal); tumors with moderate clear cells over 25% but less than 50% = grade 2 (moderate); tumors composed of greater than 50% clear cells = grade 3 (diffuse). Statistical analysis was performed to compare differences between groups in terms of clear cell composition with Pearson chi-square test using IBM SPSS version 22, and a p-value < 0.05 was considered statistically significant.
Results
The final number of cases included in the study was 535. Examples of specimens graded as levels 0-3 may be seen in figure 1. An overall comparison between 0-1 (none to focal) clear cell score to 2-3 (moderate to diffuse) clear cell score in terms of demographics, clinical information, and diagnoses is presented in table 1. Of the overall 535 cases analyzed, 425 (79.4%) showed 0-1 grade clear cell change and 110 (20.6%) showed 2-3 grade clear cell change. Gender was documented for all 535 cases, with a distribution of 230 males and 305 females. Age was provided for 517/535 cases showing 171 patients under 50 years of age and the great majority being age 50 and above, with 346. The slight majority of patients reporting duration of symptoms noted the lesions were present less than 1 year at time of biopsy (n=171/335 reported) with the remainder reporting the lesions present over 1 year (n=164/335 reported). There were no statistically significant differences in clear cell group levels in regards to gender, age group, or length of time that symptoms were reported prior to biopsy. A comparison of clear cell level by oral cavity locations is summarized in figure 2 . The majority of clear cell grade 2-3 occurred on the floor of mouth, followed in descending order by the retromolar pad, lower lip, palate, tongue, buccal mucosa, vestibule, maxillary tuberosity and upper lip. A statistically significant difference was noted between locations in terms of clear cell grade 0-1 as compared to grade 2-3 (p=0.001). e280 was a statistical difference in comparison to benign tumors (p=0.000).
Discussion
The cases described in our series contribute one of the largest case series of salivary gland tumors described in the literature. For the most part, the demographics of the cases in our series are commensurate to the parameters previously reported. The mean age affected was 57.7 years which is similar to overall rates mentioned in the literature for salivary tumors (4). Females comprised 57% of the patients in the study, which is also consistent with most cited reports (4). Due to the nature of our biopsy service which is comprised mainly of submissions from private practice offices not involving a hospital setting, parotid tumor submissions were rare, and most cases represented minor salivary gland based tumors. The benign to malignant ratio in this study was close to equal, which is typical of minor salivary gland tumors (4). PA was the most common benign tumor in the study and MEC the most common malignancy, which fits with prior studies (2,5). As expected, tumors arising mainly in the parotid were infrequent [AcCC, epithelial myoepithelial carcinoma (EMC), salivary duct carcinoma (SDC), basal cell adenoma (BCA), basal cell adenocarcinoma (BCAC)] or not represented (Warthin tumor, oncocytoma). The most common locations of tumors in our series were palate, followed by buccal mucosa, then upper lip which is consistent with reported locations for minor salivary gland lesions (4). Our study found clear cell change to be more common in malignant salivary tumors compared to benign, which is compatible with prior reports (1) . To the best of our knowledge, this study is the first to evaluate clear cell change in regards to age, gender, duration of time reported, or location of tumor. We found no significant association of clear cell change with respect to age, gender, or duration of time reported. The association noted with location are explainable primarily due to the predominance of tumors which may occur at those locations, as floor of mouth and retromolar pad had higher than overall clear cell change but had high rate of MEC in these areas (a tumor with high clear cell change), whereas upper lip had a lower than average clear cell rate but a predominance of CA in this location, a tumor which failed to show clear cell change. We were unable to measure outcome of the tumors due to the retrospective nature of the study and due to the fact that the majority of cases originated from offices 
Conclusions
In conclusion, in our study population, tumors of primarily ductal origin rarely showed clear cell change, and malignant tumors were significantly more likely than benign to exhibit more extensive clear cell change. Location was somewhat predictive of clear cell change in this study population, but explainable by prevalence of certain tumors in specific locations. Age, gender, and duration were not predictive of clear cell change. Clinicians and pathologists should carefully consider other clear cell tumors in the differential diagnosis when confronted with a salivary tumor with predominant clear cell change.
